Navigating the Diagnostic Gap in Precision Medicine
Explore the critical diagnostic gaps in precision medicine and how insurance coverage impacts patient access to essential tests, preventing effective treatment.
Explore the critical diagnostic gaps in precision medicine and how insurance coverage impacts patient access to essential tests, preventing effective treatment.
HHS renews LymeX Innovation Accelerator to boost AI-driven diagnostics and expands Medicare support for Lyme disease patients, advancing national care strategies.
Exact Sciences gains Buy ratings as Cologuard Plus expands in-network Medicare Advantage coverage, boosting reimbursement and revenue potential in cancer screening diagnostics.
The Supreme Court's 2025 ruling affirms ACA preventive service coverage, shaping pharmaceutical, diagnostic, and insurance sector investments amid evolving HHS regulations.